Tetraneuron completed a €5M funding round
19 December 2025
19 December 2025
Total investments received (USD): 14.08M
Round value (USD): 5.78M
Round investors: Gimic VenturesJJDC - Johnson & Johnson
Company: Tetraneuron
Industry: Health servicesPharma
Related deals
Pharmacelera secured €6 million in a round led by Heran Partners, joined by Clave Capital, Inveready and Bio & Tech Smart Capital.
Investments
02 February 2026
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom